Approved Antiviral Drugs over the Past 50 Years

By E. De Clercq, Guangdi Li. Clinical Microbiology Reviews, 2016

1,139 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/9fedd6e380ebcf908f8fac27e8237822250a2408

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Ralph S. Baric

In Infectious Diseases

1. Ralph S. Baric
2. Joy Y. Feng
3. Rachel L. Graham

In Molecular Biology

1. M. Manoharan
2. Martin Egli
3. Ralph S. Baric

Citations in the corpus

• Chemistry, structure and function of approved oligonucleotide therapeutics (2023, background): “VITRAVENE (fomivirsen) was the first antisense therapeutic approved by the FDA, and the only antiviral oligonucleotide-based drug brought to market to date (9,10,171).”
• Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease (2018, background): “Nucleoside analogues commonly target viral replication, particularly the viral DNA or RNA polymerase (14), and have succeeded clinically in treating multiple viral infections (15).”